(Press-News.org) MINNEAPOLIS/ST. PAUL (12/05/2023) – Researchers have discovered a novel mechanism whereby the SARS-CoV-2 virus, which causes COVID-19, can vary its mode of infection in human cells. Published in the journal eLife, a team from the University of Minnesota and the Midwest Antiviral Drug Discovery (AViDD) Center found the virus can alternate between being highly infectious and avoiding detection by the immune system. This understanding is vital for grasping the virus' impact during the pandemic and for predicting its potential evolutionary developments.
The spike protein of the virus, which is crucial for attaching to and infecting human cells, includes a flexible section known as the receptor-binding domain (RBD). Fang Li, PhD, and his team at the University of Minnesota made an early breakthrough in the pandemic, finding the RBD of SARS-CoV-2 doesn't always remain in an accessible, "ready to connect" state. They proposed that the capacity of the RBD to alter its configuration permits the virus to either unveil itself for binding with human cells or shield itself from the immune system's antibodies.
In their recent research, scientists examined the variances between SARS-CoV-2 and its relative, the SARS-CoV-1 virus responsible for the SARS outbreak from 2002 to 2003. They pinpointed a particular area of the spike protein that determines the configuration of the RBD. Variations in this segment can shift the virus toward a more infectious state by opening up, or a more elusive state by closing off.
"When a novel coronavirus first emerges in humans, it often encounters minimal immune resistance and tends to be highly infectious,” explained Dr. Li, a professor and endowed chair of pharmacology at the U of M Medical School and co-director of the Midwest AViDD Center. “As immunity develops among people, whether through infection or vaccination, the virus may increasingly resort to more elusive strategies to remain undetected. We have come to understand how a coronavirus can accomplish this evolution.”
Li added that SARS-CoV-2 was particularly notable for its ability to strike a balance between high transmissibility and the capacity to evade the immune system from the outset of the pandemic.
At the Midwest AViDD Center, Dr. Li's team is also working on innovative treatments using nanobodies — tiny antibodies derived from animals like alpacas — that can target SARS-CoV-2 even when it's in “stealth mode.” The study indicates these nanobodies have a significant advantage over conventional human antibodies in detecting and neutralizing SARS-CoV-2.
The research was co-led by Dr. Li and Bin Liu, PhD, associate professor at The Hormel Institute and investigator of the Midwest AViDD Center, with important contributions from postdoctoral pharmacology researchers Qibin Geng and Yushun Wan. Funding support for this study was provided by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, through the following grants: R01AI089728, R01AI110700, R01AI157975, and U19AI171954.
###
About the Midwest AViDD Center
The Midwest AViDD Center is developing the next generation of antiviral drugs for pandemic-level viruses, including SARS-CoV-2, Ebola, Lassa, and Zika. Headquartered at the University of Minnesota and including 18 other institutions nationwide, the Midwest AViDD Center is part of a network of nine national centers established by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
About the University of Minnesota Medical School
The University of Minnesota Medical School is at the forefront of learning and discovery, transforming medical care and educating the next generation of physicians. Our graduates and faculty produce high-impact biomedical research and advance the practice of medicine. We acknowledge that the U of M Medical School, both the Twin Cities campus and Duluth campus, is located on traditional, ancestral and contemporary lands of the Dakota and the Ojibwe, and scores of other Indigenous people, and we affirm our commitment to tribal communities and their sovereignty as we seek to improve and strengthen our relations with tribal nations. For more information about the U of M Medical School, please visit med.umn.edu.
About The Hormel Institute
The Hormel Institute is an independent biomedical research department within the University of Minnesota's Office of the Vice President for Research. Collaborative research partners include Masonic Cancer Center UMN (a Comprehensive Cancer Center as designated by the National Cancer Institute, NIH), Mayo Clinic, and many other leading research centers worldwide. The Hormel Institute, which tripled in size in 2008 and doubled again in size in 2016, is home to some of the world’s most cutting-edge research technologies and expert scientists. Over the next few years, The Hormel Institute will broaden its impact through innovative, world-class research in its quest to improve human health.
END
New study highlights COVID-19’s adaptive strategy for infection
2023-12-05
ELSE PRESS RELEASES FROM THIS DATE:
Type 1 diabetes: B cell-derived natural antibodies suppress autoimmune pathogenesis
2023-12-05
BIRMINGHAM, Ala. – Researchers have discovered the novel mechanism that underlies a previously reported observation that infection by group A Streptococcus bacteria reduces the risk of later developing Type 1 diabetes.
The Journal of Immunology reports that vaccination of neonatal mice with group A Streptococcus promoted a clonal expansion of innate-like B cells that produce antibody against N-acetyl-D-glucosamine, or GlcNAc. GlcNAc is a derivative of glucose sugar that is found as part of the cell wall of group ...
Cable-Dunlap, Chi, Smith and Thornton named ORNL Corporate Fellows
2023-12-05
Four researchers at the Department of Energy’s Oak Ridge National Laboratory have been named ORNL Corporate Fellows in recognition of significant career accomplishments and continued leadership in their scientific fields.
Corporate Fellow is the highest recognition for members of the ORNL research staff. Paula Cable-Dunlap, Miaofang Chi, Scott Smith and Peter Thornton have been recognized by the laboratory for their standing in the international scientific community as exceptional and influential researchers and as role models and mentors among peers and early career researchers.
“Paula, Miaofang, Scott and Peter represent ...
UofL secures $6.5 million to enhance training for nursing professionals
2023-12-05
The University of Louisville has received $6.5 million through two federal grants to help increase Kentuckians’ access to health care, particularly in underserved rural and urban areas. The UofL School of Nursing will use the funds from the Health Resources and Services Administration (HRSA) to develop and implement an accelerated Licensed Practical Nurse-to-Bachelor of Science in Nursing (LPN-to-BSN) pathway in medically underserved areas of Kentucky. The second HRSA-funded project aims ...
Reverse metabolomics: new method finds biomarker for inflammatory bowel disease
2023-12-05
In recent years, microbiome research has started to shift its focus from the microbes themselves to the molecules they produce. After all, it’s these molecules that directly interact with human cells to influence a person’s health. But trying to identify which molecules are being made by a person’s microbiome is quite challenging. A typical metabolomics study can only characterize about 10% of the molecular data from a human microbiome sample.
In a new study published on December 5, 2023 in Nature, microbiome experts at University of California San Diego ...
Older organs accelerate aging in transplant recipients
2023-12-05
Most organ transplantations involve supply from older donors to younger recipients. Aging cells can become senescent, a condition in which they stop multiplying and secrete chemicals that negatively affect neighboring cells. Senescent cells accumulate in older donor organs, and have the potential to compromise transplant outcomes.
A study led by researchers from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, found that in preclinical models, transplanting older organs can trigger ...
Pregnant women are missing vital nutrients needed for them and their babies – and situation could worsen with plant-based foods
2023-12-05
Pregnant women are not getting the essential nutrients they and their babies need from modern diets say scientists, who have warned that the situation will likely worsen as more people turn to plant-based foods.
A study looking at the health of expecting mothers from high-income countries, including the UK, New Zealand and Singapore, found that 90 per cent were lacking key vitamins necessary for healthy pregnancies and the wellbeing of unborn infants.
Scientists from the University of Southampton, working with experts worldwide, surveyed more than 1,700 women and found most were missing essential nutrients found in abundance in meat and dairy products.
These included vitamins B12, B6 and ...
Cell-type-specific genetic risk contributes to distinct stages of Alzheimer’s disease progression
2023-12-05
Developing treatments for Alzheimer's disease (AD) is difficult because complex underlying mechanisms drive different types of cells that may contribute to the disorder. Microglia and astrocytes, resident immune and support cells in the central nervous system, are known to exclusively express several genes linked to risk of AD — particularly AD dementia. However, it was previously unclear exactly how and when these genetic risk factors contributed to other, distinct stages of AD progression, such as the accumulation of amyloid-β plaques and tau tangles.
Researchers led by a team at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare ...
Argonne physicist recognized for “Top Cited Paper” by Institute of Physics
2023-12-05
A paper co-authored by physicist Filip Kondev of the U.S. Department of Energy’s (DOE) Argonne National Laboratory has earned a “Top Cited Paper Award” from IOP Publishing, the publishing arm of the Institute of Physics.
The paper, “The NUBASE2020 evaluation of nuclear physics properties,” provides researchers with recommended values of the basic nuclear physics properties for all known atomic nuclei. These data are provided for each nucleus in its ground state, its lowest energy level, and in its excited, isomeric state, a higher energy level that lives longer than what is typical. These data constitute the fundamental ...
Researchers identify altered functional brain connectivity in autism subtypes
2023-12-05
Philadelphia, December 5, 2023 – What happens in the brain to cause many neurodevelopmental disorders, including autism spectrum disorder (ASD), remains a mystery. A major limitation for researchers is the lack of biomarkers, or objective biological outputs, for these disorders, and in the case of ASD, for specific subtypes of disease. Now, a new study uses brain imaging and machine learning to identify altered functional brain connectivity (FC) in people with ASD – importantly, taking ...
Tanyu collecting instrumentation data from RAP-aggregate base project on Minnieville road
2023-12-05
Tanyu Collecting Instrumentation Data From RAP-Aggregate Base Project On Minnieville Road
Burak Tanyu, Professor, Civil, Environmental and Infrastructure Engineering (CEIE); Director of CEIE Laboratories, received $36,674 from the Virginia Department of Transportation (VDOT) for: "Collection of Instrumentation Data From the RAP-Aggregate Base Project on Minnieville Road."
Mason's Sustainable Geotransportation Infrastructure (SGI) research team has access to an actual roadway site located in Minnieville, Virginia, ...